T Cell-Intrinsic Interferon Regulatory Factor 1 Expression Suppresses Differentiation of CD4


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
27 09 2021
Historique:
pubmed: 5 8 2021
medline: 29 3 2022
entrez: 4 8 2021
Statut: ppublish

Résumé

Gammaherpesviruses are ubiquitous pathogens that establish lifelong infection and are associated with B cell lymphomas. To establish chronic infection, these viruses usurp B cell differentiation and drive a robust germinal center response to expand the latent viral reservoir and gain access to memory B cells. Germinal center B cells, while important for the establishment of latent infection, are also thought to be the target of viral transformation. The host and viral factors that impact the gammaherpesvirus-driven germinal center response are not clearly defined. We show that the global expression of the antiviral and tumor suppressor interferon regulatory factor 1 (IRF-1) selectively attenuates the murine gammaherpesvirus 68 (MHV68)-driven germinal center response and restricts the expansion of the latent viral reservoir. In this study, we found that T cell-intrinsic IRF-1 expression recapitulates some aspects of the antiviral state imposed by IRF-1 during chronic MHV68 infection, including the attenuation of the germinal center response and viral latency in the spleen. We also discovered that global and T cell-intrinsic IRF-1 deficiency leads to an unhindered rise of interleukin-17A (IL-17A)-expressing and follicular helper T cell populations, two CD4

Identifiants

pubmed: 34346769
doi: 10.1128/JVI.00726-21
pmc: PMC8475519
doi:

Substances chimiques

Interferon Regulatory Factor-1 0
Interleukin-17 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0072621

Subventions

Organisme : American Cancer Society (ACS)
ID : 134165-PF-19-176-01-MPC
Organisme : HHS | NIH | National Cancer Institute (NCI)
ID : CA203923
Organisme : NCI NIH HHS
ID : R01 CA203923
Pays : United States
Organisme : HHS | NIH | National Cancer Institute (NCI)
ID : CA243364
Organisme : NCI NIH HHS
ID : F31 CA243364
Pays : United States

Références

Annu Rev Pathol. 2014;9:349-72
pubmed: 24111911
Front Immunol. 2018 Oct 25;9:2469
pubmed: 30410492
J Virol. 2005 Dec;79(23):14668-79
pubmed: 16282467
J Virol. 2005 Mar;79(5):2891-9
pubmed: 15709008
Nat Rev Immunol. 2003 Oct;3(10):801-12
pubmed: 14523386
PLoS Pathog. 2011 Nov;7(11):e1002371
pubmed: 22114555
J Gen Virol. 1990 Jun;71 ( Pt 6):1365-72
pubmed: 2161903
mBio. 2021 Apr 6;12(2):
pubmed: 33824206
J Virol. 2017 Sep 12;91(19):
pubmed: 28701397
Virology. 2011 Nov 25;420(2):73-81
pubmed: 21943826
Immunity. 1996 Oct;5(4):365-76
pubmed: 8885869
J Virol. 1999 May;73(5):4029-41
pubmed: 10196299
J Exp Med. 2000 Oct 2;192(7):943-52
pubmed: 11015436
J Exp Med. 1991 Feb 1;173(2):383-93
pubmed: 1988541
Cell Rep. 2020 Dec 1;33(9):108451
pubmed: 33264614
J Immunol. 1995 Aug 1;155(3):1286-95
pubmed: 7636195
Virology. 2000 Jan 5;266(1):17-25
pubmed: 10612656
J Virol. 1997 Aug;71(8):5894-904
pubmed: 9223479
Virology. 2010 Sep 15;405(1):50-61
pubmed: 20557919
J Virol. 2004 Aug;78(15):8359-71
pubmed: 15254208
J Virol. 2010 Jan;84(2):1158-68
pubmed: 19889783
Immunity. 2002 Dec;17(6):703-12
pubmed: 12479817
PLoS Pathog. 2011 Sep;7(9):e1002230
pubmed: 21909274
Immunity. 1997 Jun;6(6):673-9
pubmed: 9208840
Nat Immunol. 2007 Sep;8(9):958-66
pubmed: 17676043
J Immunol. 2000 Oct 1;165(7):3970-7
pubmed: 11034406
Virology. 2006 Sep 15;353(1):210-9
pubmed: 16797052
PLoS Pathog. 2014 May 01;10(5):e1004106
pubmed: 24789087
J Exp Med. 1999 Aug 16;190(4):567-76
pubmed: 10449527
Cell. 1993 Oct 8;75(1):83-97
pubmed: 8402903
PLoS Pathog. 2009 Nov;5(11):e1000677
pubmed: 19956661
Science. 2014 Aug 1;345(6196):573-7
pubmed: 24968940
J Immunol. 1999 Aug 1;163(3):1529-36
pubmed: 10415056
Annu Rev Immunol. 2011;29:351-97
pubmed: 21219186
J Virol. 2005 Feb;79(4):2573-83
pubmed: 15681457
J Immunol. 2015 Mar 15;194(6):2746-56
pubmed: 25662997
J Virol. 2009 Jul;83(13):6484-93
pubmed: 19386718
Immunity. 1997 Aug;7(2):243-54
pubmed: 9285409
J Virol. 2015 Dec 30;90(6):2818-29
pubmed: 26719266
J Virol. 2005 Nov;79(22):14149-60
pubmed: 16254350
J Immunol. 2000 Feb 15;164(4):1820-8
pubmed: 10657630
J Virol. 2009 Apr;83(8):3968-76
pubmed: 19193789
J Virol. 2004 Jul;78(13):6827-35
pubmed: 15194758
Annu Rev Immunol. 2008;26:535-84
pubmed: 18303999
Virology. 2005 Aug 1;338(2):201-8
pubmed: 15961135
J Virol. 2016 Dec 16;91(1):
pubmed: 27795415
J Virol. 1993 Sep;67(9):5247-52
pubmed: 8394447
J Leukoc Biol. 2016 Jun;99(6):1153-64
pubmed: 26729813
J Virol. 2008 Dec;82(24):12205-12
pubmed: 18922872
J Virol. 2006 Jan;80(1):192-200
pubmed: 16352543
J Virol. 2019 Dec 12;94(1):
pubmed: 31597758
Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):7061-6
pubmed: 26038559
Virology. 2016 May;492:140-4
pubmed: 26945150
J Virol. 2002 Jul;76(14):7125-32
pubmed: 12072512
J Exp Med. 1996 Sep 1;184(3):863-71
pubmed: 9064346
Cell Host Microbe. 2009 Feb 19;5(2):166-78
pubmed: 19218087
J Immunol. 2017 Aug 1;199(3):1163-1169
pubmed: 28637904
PLoS Pathog. 2015 Apr 13;11(4):e1004831
pubmed: 25875847
Immunity. 1997 Jun;6(6):681-9
pubmed: 9208841
J Exp Med. 2002 Nov 18;196(10):1363-72
pubmed: 12438427
J Exp Med. 2008 Mar 17;205(3):669-84
pubmed: 18332178
J Virol. 1999 Apr;73(4):3273-83
pubmed: 10074181
Int Immunol. 1999 Aug;11(8):1185-94
pubmed: 10421776
Virology. 1999 Sep 1;261(2):173-9
pubmed: 10497103
Immunity. 2008 Dec 19;29(6):899-911
pubmed: 19062315
J Virol. 2014 Jun;88(12):6993-7004
pubmed: 24719409
J Virol. 2020 Jun 16;94(13):
pubmed: 32321819
Int Immunol. 2015 Mar;27(3):143-52
pubmed: 25280793
J Virol. 2007 Jun;81(11):6134-40
pubmed: 17360749
Cell. 2006 Sep 22;126(6):1121-33
pubmed: 16990136

Auteurs

C N Jondle (CN)

Department of Microbiology and Immunology, Medical College of Wisconsingrid.30760.32, Milwaukee, Wisconsin, USA.

K E Johnson (KE)

Department of Microbiology and Immunology, Medical College of Wisconsingrid.30760.32, Milwaukee, Wisconsin, USA.

W P Mboko (WP)

Department of Microbiology and Immunology, Medical College of Wisconsingrid.30760.32, Milwaukee, Wisconsin, USA.

V L Tarakanova (VL)

Department of Microbiology and Immunology, Medical College of Wisconsingrid.30760.32, Milwaukee, Wisconsin, USA.
Cancer Center, Medical College of Wisconsingrid.30760.32, Milwaukee, Wisconsin, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH